ClinicalTrials.gg
Drug

Baclofen clinical trials

Also written Lioresal and Kemstro.

studies test it
77
open now
5
in phase 3
18
first study started
1997
Related medicines add 1 study

Counted the way a researcher would: Baclofen with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Baclofen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Baclofen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Nov 1977 · LIORESAL · NDA 017851 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Baclofen
55
Baclofen 10mg
5
Liofen
2
Beklo
2
intrathecal baclofen
2

Brand

Lioresal
13
Kemstro
3
Gablofen
2

Studies by the year they started

76 studies that test it; most in 2013 (8)

Studies that test Baclofen, by start year
YearStudies
19971
20035
20042
20056
20073
20082
20094
20105
20111
20127
20138
20143
20153
20164
20173
20183
20202
20213
20224
20232
20241
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
9
Phase 2
29
Phase 3
18
Phase 4
16
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 69

Tanta University (3) · VA Office of Research and Development (3) · University of Pennsylvania (3) · Children's Hospital Medical Center, Cincinnati (2) · University Hospital, Toulouse (2) · Assistance Publique - Hôpitaux de Paris (2) · Imperial College London (2) · University of North Carolina, Chapel Hill (2)

Often tested with

Tested in the same studies.

Memantine (3) · Gabapentin (3) · Tizanidine (2) · Botulinum toxin type A (2) · Roflumilast (1) · Naltrexone (1) · Sorbitol (1) · Chlorzoxazone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Baclofen.

Studies

Open first, then newest update. How each study uses Baclofen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 77

See all 77 studies that test Baclofen →

Given beside what is tested · 2 — Baclofen is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Baclofen

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Baclofen · ClinicalTrials.gg INT007043

  • MeSH (NLM) D001418BaclofenConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) H789N3FKE8BACLOFENConfirmed FDA, NLM, Wikidata
  • RxNorm 1292Confirmed FDA, Wikidata
  • Wikidata Q413717(RS)-baclofenConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C28858BaclofenOne source FDA
  • DrugBank DB00181One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.